The universality of bioenergetic disease. Age-associated cellular bioenergetic degradation and amelioration therapy

Annals of the New York Academy of Sciences

Volumn 854, Issue , 1998, Pages 202-213

  Linnane, Anthony W ^a   Kovalenko, S ^a   Gingold, E B ^a  

^a EPWORTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; UBIQUINONE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; BIOCHEMISTRY; BIOENERGY; CELL AGING; CHROMOSOME MOSAICISM; CONFERENCE PAPER; DEGENERATIVE DISEASE; DELETION MUTANT; GENE MUTATION; HEART FAILURE; LIFE EXPECTANCY; MITOCHONDRIAL RESPIRATION; MUSCLE ATROPHY; MYOPATHY; NONHUMAN; ORGAN; OXIDATION REDUCTION REACTION; PHYSIOLOGY; RAT; SENESCENCE; TISSUE; VASCULAR DISEASE;

ANIMALIA;

EID: 0032409516     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09903.x     Document Type: Conference Paper

References (60)

1. LINNANE, A.W., S. MARZUKI, T. OZAWA & M. TANAKA. 1989. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1: 642-645.
2. ANDERSON, S., A.T. BANKIER, B.G. BARRELL, M.H. DE BRUIJN, A.R. COULSON, J. DROUIN, I.C. EPERON, D.P. NIERLICH, B.A. ROE, F. SANGER, P.H. SCHREIER, A.J. SMITH, R. STADEN & I.G. YOUNG. 1981. Sequence and organization of the human mitochondrial genome. Nature 290: 457-465.
3. CLAYTON, D.A. 1982. Replication of animal mitochondrial DNA. Cell 28: 693-705.
4. BOGENHAGEN, D. & D.A. CLAYTON. 1974. The number of mitochondrial deoxyribonucleic acid genomes in mouse L and human HeLa cells. Quantitative isolation of mitochondrial deoxyribonucleic acid. J. Biol. Chem. 249: 7991-7995.
5. LINNANE, A.W., C. ZHANG, A. BAUMER & P. NAGLEY. 1992. Mitochondrial DNA mutation and the ageing process: bioenergy and pharmacological intervention. Mutat. Res. 275: 195-208.
6. CRANE, F.L. 1989. Comments on the discovery of coenzyme Q: A commentary on 'Isolation of a Quinone from Beef Heart Mitochondria.' Biochim. Biophys. Acta 1000: 358-361.
7. CRANE, F.L. & D.J. MORRE. 1977. Evidence for coenzyme Q function in Golgi membranes. In Biomedical and Clinical Aspects of Coenzyme Q. K. Folkers & Y. Yamamura, Eds.: Vol. 1: 3-14. Elsevier. Amsterdam.
8. KALEN, A., B. NORLING, E.L. APPELKVIST & G. DALLNER. 1987. Ubiquinone biosynthesis by the microsomal fraction from rat liver. Biochim. Biophys. Acta 926: 70-78.
9. SUN, I.L., E.E. SUN, F.L. CRANE, D.J. MORRE, A. LINDGREN & H. LOW. 1992. Requirement for coenzyme Q in plasma membrane electron transport. Proc. Natl. Acad. Sci. USA 89: 11126-11130.
10. LENAZ, G., R. FATO, C. CASTELLUCCIO, M.L. GENOVA, C. BOVINA, E. ESTORNELL, V. VALLS, F. PALLOTTI & G. PARENTI CASTELLI. 1993. The function of coenzyme Q in mitochondria. Clin. Invest. 71: S66-70.
11. BEYER, R.E., K. NORDENBRAND & L. ERNSTER. 1987. The function of coenzyme Q in free radical production and as an antioxidant: A review. Chem. Scr. 27: 145-153.
12. ERNSTER, L. & R.E. BEYER. 1991. Antioxidant functions of coenzyme Q: Some functional and pathophysiological implications. In Biomedical and Clinical Aspects of Coenzyme Q. K. Folkers, G.P. Littarru & Y. Yamagami, Eds.: Vol. 6: 45-58. Elsevier. Amsterdam.
13. KAGAN, V.E., H. NOHL & P.J. QUINN. 1996. Coenzyme Q: Its role in scavenging and generation of radicals in membranes. In Textbook of Antioxidants. E. Cadenas & L. Packer, Eds.: 157-201. M. Dekken Inc. New York.
14. OZAWA, T. 1985. Formation of oxygen radicals in the electron transport chain and antioxidant properties of coenzyme Q. In Coenzyme Q: Biochemistry, Bioenergetics and Clinical Applications of Ubiquinone. G. Lenaz, Ed.: 441-456. John Wiley. Chichester.
15. FOLKERS, K., G.P. LITTARRU & T. YAMAGAMI. 1991. Biomedical and clinical aspects of coenzyme Q, Vol. 6. Elsevier. Amsterdam.
16. 10 putatively acting through the plasma membrane oxidase. Biochem. Mol. Biol. Int. 31: 997-1005.
17. LINNANE, A.W., M. DEGLI ESPOSTI, M. GENEROWICZ, A.R. LUFF & P. NAGLEY. 1995. The universality of bioenergetic disease and amelioration with redox therapy. Biochim. Biophys. Acta 1271: 191-194.
18. ESPOSTI, M.D., A. NGO, A. GHELLI, B. BENELLI, V. CARELLI, H. McLENNAN & A.W. LINNANE. 1996. The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria. Arch. Biochem. Biophys. 330: 395-400.
19. HOLT, I.J., A.E. HARDING & J.A. MORGAN-HUGHES. 1988. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331: 717-719.
20. WALLACE, D.C. 1994. Mitochondrial DNA mutations in diseases of energy metabolism. J. Bioenerg. Biomembr. 26: 241-250.
21. SCHAPIRA, A.H.V. 1994. Respiratory chain adnomalities in human disease. In Mitochondria: DNA, Protein and Disease. V. Darley-Usmar & A.H.V. Schapira, Eds.: 241-278. Portland Press. London.
22. LINNANE, A.W., A. BAUMER, R.J. MAXWELL, H. PRESTON, C.F. ZHANG & S. MARZUKI. 1990. Mitochondrial gene mutation: The ageing process and degenerative diseases. Biochem. Int. 22: 1067-1076.
23. NAGLEY, P., I.R. MACKAY, A. BAUMER, R.J. MAXWELL, F. VAILLANT, Z.-X. WANG, C. ZHANG & A.W. LINNANE. 1992. Mitochondrial DNA mutation associated with aging and degenerative disease. Ann. N. Y. Acad. Sci. 673: 92-102.
24. ZHANG, C., A. BAUMER, R.J. MAXWELL, A.W. LINNANE & P. NAGLEY. 1992. Multiple mitochondrial DNA deletions in an elderly human individual. FEBS Lett. 297: 34-38.
25. ZHANG, C., A.W. LINNANE & P. NAGLEY. 1993. Occurrence of a particular base substitution (3243 A to G) in mitochondrial DNA of tissues of aging humans. Biochem. Biophys. Res. Commun. 195: 1104-1110.
26. WALLACE, D.C. 1992. Mitochondrial genetics: A paradigm for aging and degenerative diseases? Science 256: 628-632.
27. WEI, Y.H. 1992. Mitochondrial DNA alterations as ageing-associated molecular events. Mutat. Res. 275: 145-155.
28. CORTOPASSI, G.A. & N. ARNHEIM. 1990. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res. 18: 6927-6933.
29. SIMONETTI, S., X. CHEN, S. DIMAURO & E.A. SCHON. 1992. Accumulation of deletions in human mitochondrial DNA during normal aging: Analysis by quantitative PCR. Biochim. Biophys. Acta 1180: 113-122.
30. ZHANG, C., L.E. PETERS, A.W. LINNANE & P. NAGLEY. 1996. Comparison of different quantitative PCR procedures in the analysis of the 4977-bp deletion in human mitochondrial DNA. Biochem. Biophys. Res. Commun. 223: 450-455.
31. KOVALENKO, S.A., G. KOPSIDAS, J.M. KELSO & A.W. LINNANE. 1997. Deltoid human muscle mtDNA is extensively rearranged in old age subjects. Biochem. Biophys. Res. Commun. 232: 147-152.
32. MULLER-HOCKER, J., K. SCHNEIDERBANGER, F.H. STEFANI & B. KADENBACH. 1992. Progressive loss of cytochrome c oxidase in the human extraocular muscles in ageing- A cytochemical-immunohistochemical study. Mutat. Res. 275: 115-124.
33. KOPSIDAS, G., S.A. KOVALENKO, J.M. KELSO & A.W. LINNANE. 1998. Age associated bioenergy degradation: A definitive correlation between cellular bioenergy decline and extensive mtDNA rearrangements in human skeletal muscle. Mutat. Res. In press.
34. 3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc. Natl. Acad. Sci. USA 81: 3529-3533.
35. 10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy. Cell. Mol. Biol. 43: 741-749.
36. 10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. Eur. Neurology 37: 212-218.
37. 10. Bratisl. Lek. Listy 95: 443-451.
38. 10 deficiency. Neurology 48: 1238-1243.
39. 10 in essential hypertension. Mol. Aspects Med. 15 Suppl: s257-263.
40. DUNLOP, I.S. & P. DUNLOP. 1995. Reversible ophthalmoplegia in CPEO. Aust. N.Z. J. Ophthalmology 23: 231-234.
41. 10. Biochem. Biophys. Res. Commun. 192: 241-245.
42. 10 during heart surgery. Clin. Invest. 71: S155-161.
43. 10. Mol. Aspects Med. 15 Suppl: S265-272.
44. 10 (ubiquinone). Clin. Invest. 71:S116-123.
45. LENAZ, G., R. FATO, C. CASTELLUCCIO, M. BATTINO, M. CAVAZZONI, H. RAUCHOVA, & G. PARENTI CASTELLI. 1991. Coenzyme Q saturation kinetics of mitochondrial enzymes: Theory, experimental aspects and biomedical implications. In Biomedical and Clinical Aspects of Coenzyme Q. K. Folkers, G.P. Littarru & Y. Yamagami, Eds.: Vol. 6: 11-18. Elsevier. Amsterdam.
46. ESTORNELL, E., R. FATO, C. CASTELLUCCIO, M. CAVAZZONI, G. PARENTI CASTELLI & G. LENAZ. 1992. Saturation kinetics of coenzyme Q in NADH and succinate oxidation in beef heart mitochondria. FEBS Lett. 311: 107-109.
47. KALEN, A., E.L. APPELKVIST & G. DALLNER. 1989. Age-related changes in the lipid compositions of rat and human tissues. Lipids 24: 579-584.
48. VAILLANT, F., B.E. LOVELAND, P. NAGLEY & A.W. LINNANE. 1991. Some biochemical properties of human lymphoblastoid Namalwa cells grown anaerobically. Biochem. Int. 23: 571-580.
49. LINNANE, A.W. & P. NAGLEY. 1978. Mitochondrial genetics in perspective: The derivation of a genetic and physical map of the yeast mitochondrial genome. Plasmid 1: 324-345.
50. DESJARDINS, P., E. FROST & R. MORAIS. 1985. Ethidium bromide-induced loss of mitochondrial DNA from primary chicken embryo fibroblasts. Mol. Cell. Biol. 5: 1163-1169.
51. KING, M.P. & G. ATTARDI. 1989. Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation. Science 246: 500-503.
52. CHEN, X.J. & G.D. CLARK-WALKER. 1993. Mutations in MGI genes convert Kluyveromyces lactis into a petite-positive yeast. Genetics 133: 517-525.
53. CHEN, X.J. & G.D. CLARK-WALKER. 1995. Specific mutations in alpha- and gamma-subunits of F1-ATPase affect mitochondrial genome integrity in the petite-negative yeast Kluyveromyces lactis. EMBO J. 14: 3277-3286.
54. 0 cells. J. Biol. Chem. 269: 30097-30100.
55. SUN, I.L., E.E. SUN, F.L. CRANE & D.J. MORRE. 1990. Evidence for coenzyme Q function in transplasma membrane electron transport. Biochem. Biophys. Res. Commun. 172: 979-984.
56. WOLVETANG, E.J., K.L. JOHNSON, K. KRAUER, S.J. RALPH & A.W. LINNANE. 1994. Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett. 339: 40-44.
57. LAWEN, A., R.D. MARTINUS, G.L. McMULLEN, P. NAGLEY, F. VAILLANT, E.J. WOLVETANG & A.W. LINNANE. 1994. The universality of bioenergetic disease: The role of mitochondrial mutation and the putative inter-relationship between mitochondria and plasma membrane NADH oxidoreductase. Mol. Aspects Med. 15 Suppl: s13-27.
58. LAMPERTH, L., M.C. DALAKAS, F. DAGANI, J. ANDERSON & R. FERRARI. 1991. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab. Invest. 65: 742-751.
59. DALAKAS, M.C., I. ILLA, G.H. PEZESHKPOUR, J.P. LAUKAITIS, B. COHEN & J.L. GRIFFIN. 1990. Mitochondrial myopathy caused by long-term zidovudine therapy [see comments]. N. Engl. J. Med. 322: 1098-1105.
60. 10 treatment improves the tolerance of the senescent myocardium to pacing stress in the rat. Cardiovasc. Res. In press.